Effects of low and high doses of selective sigma ligands: further evidence suggesting the existence of different subtypes of sigma receptors
- 1 September 1997
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 129 (3) , 215-224
- https://doi.org/10.1007/s002130050183
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Effect of short-term and long-term treatments with σ ligands on the N -methyl-d -aspartate response in the CA3 region of the rat dorsal hippocampusBritish Journal of Pharmacology, 1997
- Modulation of nmda and dopaminergic neurotransmissions by sigma ligands: Possible implications for the treatment of psychiatric disordersLife Sciences, 1996
- NE-100, a novel sigma receptor ligand: In vivo testsLife Sciences, 1993
- BMY-14802 protects against ischemia-induced neuronal damage in the gerbilLife Sciences, 1992
- Neuropeptide Y does not alter NMDA conductances in CA3 pyramidal neurons: A slice-patch studyNeuroscience Letters, 1992
- A proposal for the classification of sigma binding sitesTrends in Pharmacological Sciences, 1992
- JO 1784, a potent and selective ligand for rat and mouse brain σ-sitesJournal of Pharmacy and Pharmacology, 1990
- Failure of σ-receptor ligands to reduce the excitatory actions of N-methyl-DL-aspartate on rat spinal neurons in-vivoJournal of Pharmacy and Pharmacology, 1990
- Potential antipsychotic BMY 14802 selectively binds to sigma sitesDrug Development Research, 1987
- Acidic amino acid binding sites in mammalian neuronal membranes: their characteristics and relationship to synaptic receptorsBrain Research Reviews, 1984